Effect of murine interferon alpha/beta on tumour-induced suppressor function.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Cancer Immunology and Immunotherapy

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8001023PMCID PMC11038840
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Defining protective responses to pathogens: cytokine profiles in leprosy lesions.

  1991cited by this paper
• Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones.

  1991cited by this paper
• Inhibition of suppressor T lymphocytes (Ts) by cimetidine.

  1987cited by this paper
• Inhibition of suppressor T lymphocytes by murine interferon beta

  1987cited by this paper
• Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses.

  1986cited by this paper
• Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions

  1986cited by this paper
• The regulation of expression of major histocompatibility complex products.

  1986cited by this paper
• Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.

  1986cited by this paper
• Preclinical biology of alpha interferons.

  1986cited by this paper
• Radiation-induced, immunologically mediated regression of an established tumor as an example of successful therapeutic immunomanipulation. Preferential elimination of suppressor T cells allows sustained production of effector T cells

  1986cited by this paper
• HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.

  1985cited by this paper
• Immunoregulatory pathways in adult responder mice. III. Establishment of a GAT-specific suppressor T cell clone from GAT-tolerant responders which afferently regulates DTH responses.

  1985cited by this paper
• Specificity of the T Cells That Mediate and Suppress Adoptive Immunotherapy of Established Tumors

  1984cited by this paper
• The murine antitumor immune response and its therapeutic manipulation.

  1984cited by this paper
• Suppressor T cell growth and differentiation. Identification of a cofactor required for suppressor T cell function and distinct from interleukin 2

  1984cited by this paper
• Inhibition of the T suppressor circuit of delayed-type hypersensitivity by interferon.

  1984cited by this paper
• Adoptive immunization against an established tumor with cytolytic versus memory T cells. Immediate versus delayed onset of regression.

  1984cited by this paper
• Establishment and functional analysis of a cloned, antigen-specific suppressor effector T cell line.

  1984cited by this paper
• Acetylcholine release from growth cones detected with patches of acetylcholine receptor-rich membranes

  1983cited by this paper
• Characterization of the Murine Antigenic Determinant, Designated L3T4a, Recognized by Monoclonal Antibody GK 1.5: Expression of L3T4a by Functional T Cell Clones Appears to Correlate Primarily with Class II MHC Antigen‐Reactivity

  1983cited by this paper
• Specific suppression of responses to Leishmania tropica by a cloned T-cell line

  1983cited by this paper
• Suppressor T lymphocytes control the development of primary skin cancers in ultraviolet-irradiated mice.

  1982cited by this paper
• A human suppressor T cell clone which recognizes an autologous helper T cell clone

  1982cited by this paper
• A cloned T-cell line from a tolerant mouse represents a novel antigen-specific suppressor cell type

  1982cited by this paper
• Antigen-specific T lymphocyte clones. I. Characterization of a T lymphocyte clone expressing antigen-specific suppressive activity

  1981cited by this paper
• Effects of cytotoxic monoclonal antibody specific for T200 glycoprotein on functional lymphoid cell populations.

  1980cited by this paper
• Active suppression of 1-fluoro-2,4-dinitrobenzene-immune T cells. Requirement of an auxiliary T cell induced by antigen

  1979cited by this paper
• Xenogeneic Monoclonal Antibodies to Mouse Lymphoid Differentiation Antigens *

  1979cited by this paper
• Genetic restrictions for the induction of suppressor T cells by hapten- modified lymphoid cells in tolerance to 1-fluoro-2,4-dinitrobenzene contact sensitivity. Role of the H-2D region of the major histocompatibility complex

  1978cited by this paper
• Suppressor T cell mechanisms in contact sensitivity. I. Efferent blockade by syninduced suppressor T cells.

  1978cited by this paper
• Immune suppression with supraoptimal doses of antigen in contact sensitivity. I. Demonstration of suppressor cells and their sensitivity to cyclophosphamide.

  1977cited by this paper
• Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses

  1975cited by this paper
• Cell interactions in the induction of tolerance: the role of thymic lymphocytes.

  1970cited by this paper

• The Use of Registries to Improve Cancer Treatment: A National Database for Patients Treated with Interleukin-2 (IL-2)

  2014cites this paper
• Inducible nitric oxide synthase activity is essential for inhibition of prostatic tumor growth by interferon-β gene therapy

  2006cites this paper
• Inducible nitric oxide synthase activity is essential for inhibition of prostatic tumor growth by interferon-beta gene therapy.

  2006cites this paper
• Regression of primary murine colon cancer and occult liver metastasis by intralesional injection of lyophilized preparation of insect cells producing murine interferon-beta.

  2003cites this paper
• Specific immunotherapy against occult cancer metastases

  2002cites this paper
• Vitamin D3 treatment to diminish the levels of immune suppressive CD34+ cells increases the effectiveness of adoptive immunotherapy.

  2000cites this paper
• Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers.

  1999cites this paper
• Eradication of primary murine fibrosarcomas and induction of systemic immunity by adenovirus-mediated interferon beta gene therapy.

  1999cites this paper
• Stimulation of immune suppressive CD34+ cells from normal bone marrow by Lewis lung carcinoma tumors

  1998cites this paper
• Failure of tumor-reactive lymph node cells to kill tumor in the presence of immune-suppressive CD34+ cells can be overcome with vitamin D3 treatment to diminish CD34+ cell levels

  1998cites this paper
• Escape from host-antitumor immunity.

  1997cites this paper
• Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-beta and nitric oxide.

  1996cites this paper
• Vitamin D3 treatment of tumor bearers can stimulate immune competence and reduce tumor growth when treatment coincides with a heightened presence of natural suppressor cells.

  1996cites this paper